← Open Payments lookup

VENRICE KERR: Open Payments

NPI 1659517753 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$732 in 30 payments from 12 companies in 2025. Trend: 2023 $20 · 2024 $444 · 2025 $732

Food & beverage: $732
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$144
Vanda Pharmaceuticals Inc.5$133
ABBVIE INC.5$121
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$78
Alkermes, Inc.3$56
Axsome Therapeutics, Inc.2$48
E.R. Squibb & Sons, L.L.C.2$40
Janssen Pharmaceuticals, Inc1$36
Otsuka America Pharmaceutical, Inc.1$25
Tris Pharma Inc1$19

Products named: INGREZZA, VRAYLAR, HETLIOZ, CAPLYTA, Auvelity, COBENFY, ARISTADA, REXULTI.

Industry payments across MD — which companies pay providers there.